Institution
Inova Fairfax Hospital
Healthcare•Falls Church, Virginia, United States•
About: Inova Fairfax Hospital is a healthcare organization based out in Falls Church, Virginia, United States. It is known for research contribution in the topics: Population & Nonalcoholic fatty liver disease. The organization has 1227 authors who have published 1979 publications receiving 100143 citations. The organization is also known as: Fairfax Hospital.
Topics: Population, Nonalcoholic fatty liver disease, Fatty liver, Hepatitis C, Idiopathic pulmonary fibrosis
Papers published on a yearly basis
Papers
More filters
••
TL;DR: As the global epidemic of obesity fuels metabolic conditions, the clinical and economic burden of NAFLD will become enormous, and random‐effects models were used to provide point estimates of prevalence, incidence, mortality and incidence rate ratios.
6,746 citations
••
TL;DR: This guidance provides a data-supported approach to the diagnostic, therapeutic, and preventive aspects of NAFLD care.
4,431 citations
••
TL;DR: This is a practice guideline for clinicians rather than a review article and interested readers can refer to several comprehensive reviews published recently.
3,212 citations
••
TL;DR: The large number of patients with NAFLD with potential for progressive liver disease creates challenges for screening, as the diagnosis of NASH necessitates invasive liver biopsy.
Abstract: NAFLD is one of the most important causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming decades, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NAFLD vary worldwide, usually parallel to the prevalence of obesity, but a substantial proportion of patients are lean. The large number of patients with NAFLD with potential for progressive liver disease creates challenges for screening, as the diagnosis of NASH necessitates invasive liver biopsy. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their need for management. While awaiting the development effective therapies, this disease warrants the attention of primary care physicians, specialists and health policy makers.
3,076 citations
••
TL;DR: Aliment Pharmacol Ther 2011; 34: 274–285
Abstract: SUMMARY Background Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease, and its worldwide prevalence continues to increase with the growing obesity epidemic. This study assesses the epidemiology of NAFLD in adults based on clinical literature published over the past 30 years. Aim To review epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults based on clinical literature published over the past 30 years. Methods An in-depth search of PubMed (1980–2010) was based on five search terms: ‘nonalcoholic fatty liver disease’ OR ‘non-alcoholic steatohepatitis’ OR ‘fatty liver’ OR ‘steatosis’ AND ‘incidence’ [MeSH Terms] OR ‘prevalence’ [MeSH Terms] OR ‘natural history’. Studies of paediatric cohorts were excluded. Articles were categorised by topic and summarised, noting generalisations concerning their content.
2,679 citations
Authors
Showing all 1249 results
Name | H-index | Papers | Citations |
---|---|---|---|
Lance A. Liotta | 153 | 832 | 102335 |
Christopher M. O'Connor | 134 | 894 | 70357 |
Vivette D. D'Agati | 111 | 527 | 46487 |
Zobair M. Younossi | 106 | 759 | 62073 |
Randall T. Higashida | 96 | 429 | 45856 |
Emanuel F. Petricoin | 93 | 488 | 36145 |
Zachary Goodman | 86 | 302 | 41964 |
Guadalupe Garcia-Tsao | 81 | 331 | 30577 |
Bruce R. Bacon | 78 | 410 | 31928 |
Paul A. Gurbel | 77 | 589 | 28852 |
Thomas P. Conrads | 68 | 202 | 18375 |
Loren Lipworth | 57 | 216 | 12143 |
Lynn H. Gerber | 56 | 214 | 11459 |
Steven D. Nathan | 51 | 296 | 11856 |
Juan R. Cebral | 50 | 215 | 9089 |